CAFs and STC1 could upregulate the expression of cancer stemness genes (NANOG, SOX2, and OCT4), and STC1-Ab treatment blocked the promoting effect of CAFs on the expression of stemness genes in HCC cells (Fig. 1I). This evidence concerns the gene STC1 and hepatocellular carcinoma.